Food effect study of Tofogliflozin

Food effect study of Tofogliflozin(CSG452) in healthy adult male volunteers

Status

Unknown

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221804

Enrollment

Registered

2012-05-29

Start date

2012-05-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

investigational material(s) Generic name etc : Tofogliflozin INN of investigational material : Tofogliflozin Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investiga

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: -healthy volunteers -Body mass index(BMI) >=18.5 kg/m2 and =90 mL/min/1.73 m2 -Has not smoked for at least a year before screening and will not smoke during the study period

Exclusion criteria

Exclusion criteria: Has taken any of the medicines, foods and drinks that can affect the pharmacokinetics of Tofogliflozin within two weeks before administration in Period I. Etc.

Design outcomes

Primary

Measure	Time frame
Pharmacokinetics To evaluate the pharmacokinetics of Tofogliflozin when administered under fasted or fed condition.	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026